The rising interest in successful weight management has spurred considerable exploration into novel treatments. Lately , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor activator , has demonstrated positive results in clinical trials, suggesting potential for considerable weight loss . As a result , many individuals are